Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06086561 · ClinicalTrials.gov registry record · NA
Longitudinal Measurements of Flow in Cerebrospinal Fluid Shunts With a Wireless Thermal Anisotropy Measurement Device
A NA study of Hydrocephalus, sponsored by Rhaeos.
- Recruiting
- Registry status
- NA
- Development phase
- 130
- Enrollment target
- 4
- Study locations
NCT06086561: Recruiting NA study of Hydrocephalus, sponsored by Rhaeos.
NCT06086561 is a NA study of Hydrocephalus that is actively recruiting participants, run by Rhaeos. The registered enrollment target is 130 participants, roughly in line with the 126-participant average among 17 other Hydrocephalus trials with a reported enrollment target. The trial reports 4 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06086561, a NA study of Hydrocephalus, is actively recruiting participants, sponsored by Rhaeos.
- RECRUITING
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study evaluates the performance of a device for non-invasively assessing cerebrospinal fluid (CSF) shunt flow. Patients with an existing implanted shunt will wear the device to acquire longitudinal data.
Primary Outcome
Exploratory assessment of thermal skin measurements taken with the study device
Conditions Studied
Interventions
- DEVICE Thermal Anisotropy Measurement Device
Study Locations (4)
Illinois
- Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago
- MATTER - Chicago
- Northwest Special Recreation Association - Rolling Meadows
Florida
- Tampa Marriott Water Street - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2023-11-17 |
| Est. Completion | 2025-12 |
| Phase | NA |
What NCT06086561 shows while recruiting
NCT06086561 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 126-participant average among 17 other Hydrocephalus trials with a reported enrollment target.
The record links to 1 condition, with Hydrocephalus appearing as the primary indexed condition, and to 1 intervention - of which Thermal Anisotropy Measurement Device is the first listed.
NCT06086561 reports a single indexed study location in Illinois, Florida.
Frequently Asked Questions
What is clinical trial NCT06086561 about?
NCT06086561 is a clinical study titled "Longitudinal Measurements of Flow in Cerebrospinal Fluid Shunts With a Wireless Thermal Anisotropy Measurement Device". This study evaluates the performance of a device for non-invasively assessing cerebrospinal fluid (CSF) shunt flow. Patients with an existing implanted shunt will wear the device to acquire longitudinal data.
What is the current status of trial NCT06086561?
This trial is currently recruiting. It is a NA study. The enrollment target is 130 participants. The study started on 2023-11-17. Estimated completion is 2025-12.
What conditions does trial NCT06086561 study?
This clinical trial studies the following conditions: Hydrocephalus.
What interventions are being tested in trial NCT06086561?
The interventions under investigation include: Thermal Anisotropy Measurement Device (DEVICE).
Who is sponsoring clinical trial NCT06086561?
This trial is sponsored by Rhaeos, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06086561 being conducted?
This trial has 4 study locations across Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hydrocephalus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06086561's enrollment target sits among peer trials
130 6th of 17 higher than 12 of 17 other Hydrocephalus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hydrocephalus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessment of CSF Shunt Flow and Headaches With a Thermal Measurement Device
RECRUITING · NA
-
EVD Drainage Data and Intracranial Pressure (ICP) Measurements
RECRUITING · NA
-
Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4
RECRUITING · NA
-
Flow Detection in Open and Closed Shunt Valve Periods
RECRUITING · NA
-
MR Evaluation of Cerebrospinal Fluid (CSF) Dynamics
RECRUITING · NA
-
US Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI